Holen Sie sich die Stockscreener-App
6.735
0.69%
-0.045
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.78
Offen:
$6.71
24-Stunden-Volumen:
2.07M
Relative Volume:
0.50
Marktkapitalisierung:
$1.09B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
2.9539
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
+2.02%
1M Leistung:
-9.50%
6M Leistung:
-9.13%
1J Leistung:
-25.76%
1-Tages-Spanne:
$6.60
$6.86
1-Wochen-Bereich:
$6.59
$7.035
52-Wochen-Spanne:
$5.01
$11.55
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
6.735 | 1.10B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.48 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.57 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.29 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.79 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.49 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - Yahoo Finance
Lobbying Update: $30,000 of NOVAVAX lobbying was just disclosed - Quiver Quantitative
Novavax, Inc. (NVAX): A Bull Case Theory - Finviz
Novavax, Inc. (NVAX): A bull case theory - MSN
Will Novavax Inc. (NVV1) stock deliver stable dividendsMarket Movement Recap & Verified Technical Signals - Newser
How Novavax Inc. (NVV1) stock benefits from digital adoptionJuly 2025 Action & Weekly Breakout Watchlists - Newser
How Novavax Inc. (NVV1) stock gains from tech spendingRisk Management & Weekly Stock Performance Updates - Newser
Novavax (NVAX): Exploring Valuation After Prolonged Share Price Weakness - Yahoo Finance
Why pension funds invest in Novavax Inc. (NVV1) stockEarnings Summary Report & Long-Term Growth Plans - Newser
Discipline and Rules-Based Execution in NVAX Response - news.stocktradersdaily.com
Bank of America Securities Sticks to Their Sell Rating for Novavax (NVAX) - The Globe and Mail
Why Novavax Inc. stock could see breakout soonWeekly Trend Summary & AI Forecasted Stock Moves - Newser
How Novavax Inc. (NVV1) stock reacts to Fed tighteningInsider Selling & Verified Swing Trading Watchlist - Newser
Vaccine developers’ stocks dip after Prasad memo becomes public - BioCentury
Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals - The Wall Street Journal
Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals - Barron's
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barron's
Moderna Falls as FDA Vows to Impose New Vaccine Requirements - Bloomberg.com
Cash from financing activities of Novavax, Inc. – SIX:NVAX.USD - TradingView
Intech Investment Management LLC Sells 58,151 Shares of Novavax, Inc. $NVAX - MarketBeat
What drives Global Ship Lease Inc stock priceReal-Time Stock Alerts & Capital Efficiency Improvement - earlytimes.in
Will Novavax Inc. stock outperform international peersJuly 2025 Trends & Technical Pattern Recognition Alerts - BỘ NỘI VỤ
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Follow Insider Buying Trends for India Steel Works LimitedWeekly Market Snapshot & Free Stock Index Interpretations - earlytimes.in
What drives Novavax Inc stock priceMarket Profile Overview & Free Explosive Return Secrets - earlytimes.in
Can Ganga Papers India Limited Maintain Shareholder Returns via BuybacksEmerging Market Stocks & Superior Trading Portfolio - earlytimes.in
Novavax Inc. Stock Climbs 3.9%, Outperforms Peers - 富途牛牛
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast - MSN
Shah Capital continues push for potential Novavax sale - Alternatives Watch
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax’s Outlook (NVAX) - Seeking Alpha
January 2026 Options Now Available For Novavax (NVAX) - Nasdaq
Novavax’s R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX - Yahoo Finance
What Recent Partnership Efforts Mean for the Value of Novavax in 2025 - Yahoo Finance
Novavax slips as Citi launches with Sell rating on pipeline concerns - MSN
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - sharewise.com
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
9 Oversold Biotech Stocks to Invest In - Insider Monkey
Novavax rises after a seven-day slide - MSN
Behavioral Patterns of NVAX and Institutional Flows - news.stocktradersdaily.com
Novavax, UniFirst, and More Stocks See Action From Activist Investors - Barron's
Interesting NVAX Put And Call Options For July 2026 - Nasdaq
How rising interest rates impact Novavax Inc. stockWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Is Novavax Inc. stock undervalued vs historical averagesJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Will Novavax Inc. (NVV1) stock hit Wall Street targets2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Why Novavax Inc. stock appeals to dividend seekers2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Is Novavax Inc. stock a buy on dipsJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
earlytimes> 2025> Is Novavax Inc a good long term investmentCash Flow Trends & Small Investment Wealth Growth - earlytimes.in
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novavax Inc-Aktie (NVAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MCGLYNN MARGARET G | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,588 |
| Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
| King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
| Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
| MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
| DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
1.22%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):